Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

July 31, 2015 10:27 PM ET


Company Overview of Affibody Medical AB (publ)

Company Overview

Affibody Medical AB (publ), a biotechnology company, focuses on developing biopharmaceuticals based on its Affibody molecules and Albumod proprietary technology platforms. The Affibody technology includes the Affibody molecules, which are antibody mimetics that surpasses monoclonal antibodies and antibody fragments. The Albumod technology enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. It has collaboration agreements with Algeta ASA, Amylin, Daiichi Sankyo, Daewoong, Swedish Orphan Biovitrum, and GE Healthcare Bio-Sciences AB. The company was formerly known as Affibody Holding AB (publ) and changed its name to Affibody...

Gunnar Asplunds Alle 24

Solna,  171 63


Founded in 1998

22 Employees


46 8 59 88 38 00

Key Executives for Affibody Medical AB (publ)

Chief Executive Officer
Co-Founder, Deputy Chairman and Member of Scientific Advisory Board
Age: 61
Co-Founder, Chief Business Officer and Member of Technical Advisory Board
Co-Founder and Senior Vice President of Operations
Co-Founder and Member of Scientific Advisory Board
Age: 77
Compensation as of Fiscal Year 2015.

Affibody Medical AB (publ) Key Developments

Biotest AG Signs a Research License and Option Agreement with Affibody AB

Biotest AG has signed a research license and option agreement with Affibody AB to use Affibody's proprietary Albumod(TM) platform, which is designed to enhance the efficacy of biopharmaceuticals. As part of the transaction, Affibody will receive up-front and milestone payments as well as royalties on sales of Affibody.

Nordic Nanovector ASA and Affibody AB Enter into Three-Year Collaborative Research Agreement to Discover and Develop New Advanced Radio-Immunotherapies for Multiple Myeloma

Nordic Nanovector ASA and Affibody AB announced that the companies have entered into a three-year collaborative research agreement to discover and develop new advanced radio-immunotherapies (RIT) for multiple myeloma. Backed by a Eurostars grant the project will combine Affibody’s proprietary platforms with Nordic Nanovector’s radioimmunotherapy technology. The project aims to provide documentation necessary to start GMP manufacturing of the Affibody®-based RIT and subsequently start clinical trials. The companies have been awarded approximately €1 million in total by Vinnova in Sweden and The Norwegian Research Council in Norway. Upon a successful conclusion of the collaboration Nordic Nanovector will have the opportunity to license the global rights to the Affibody®- based RIT. The development of an Affibody®-based RIT treatment represents a distinct work stream to be carried out in parallel with Nordic Nanovector’s lead product candidate Betalutin™ for non-Hodgkin Lymphoma treatment.

Affibody Medical AB (publ) Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014

Affibody Medical AB (publ) Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.

Similar Private Companies By Industry

Company Name Region
Dynamic Code AB Europe
Grifols Nordic AB Europe
BioArctic Neuroscience AB Europe
PharmaSurgics in Sweden AB Europe
Woodheads AB Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Affibody Medical AB (publ), please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at